YaoGeJu

Company directoryChina company filings

Guilin Pharmaceutical Co.,Ltd.

As of 18 November 2026, for the company name Guilin Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 24 active records with this name as holder; 35 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

41 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Dotinurad Tablets 2 records · Latest accepted 2026/05/12

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601088Generic2026/05/12Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHS2601087Generic2026/05/12Guilin Pharmaceutical Co.,Ltd.CDE ↗
Pemafibrate Tablets 1 records · Latest accepted 2026/04/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600973Generic2026/04/28Guilin Pharmaceutical Co.,Ltd.; Beijing Yi Ling Bio Gong Cheng Technology Co., Ltd. romanizedCDE ↗
利伐沙班干混悬剂 · No verified English name 2 records · Latest accepted 2025/09/28

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501928Supplement2025/09/28Guilin Pharmaceutical Co.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2501927Supplement2025/09/28Guilin Pharmaceutical Co.,Ltd.; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Baloxavir Marboxil Tablets 1 records · Latest accepted 2025/07/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501471Supplement2025/07/23Guilin Pharmaceutical Co.,Ltd.; Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanizedCDE ↗
Bilastine Tablets 1 records · Latest accepted 2025/03/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501203Generic2025/03/28Guilin Pharmaceutical Co.,Ltd.CDE ↗
Josamycin Tablets 1 records · Latest accepted 2025/02/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550128Supplement2025/02/28Guilin Pharmaceutical Co.,Ltd.CDE ↗
Aspirin Enteric-coated Tablets 6 records · Latest accepted 2025/02/09

Supplement · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500265Supplement2025/02/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2500264Supplement2025/02/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2500263Supplement2025/02/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2350319Supplement2023/04/06Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2150675Supplement2021/06/18Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2150112Supplement2021/02/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
Polymyxin B sulfate for Injection 1 records · Latest accepted 2025/01/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500394Generic2025/01/22Guilin Pharmaceutical Co.,Ltd.; Suzhou Erye Pharmaceutical Co., LtdCDE ↗
Isavuconazonium Sulfate for Injection 1 records · Latest accepted 2025/01/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500348Generic2025/01/17Guilin Pharmaceutical Co.,Ltd.; Suzhou Erye Pharmaceutical Co., LtdCDE ↗
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2024/12/18

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402162Supplement2024/12/18Guilin Pharmaceutical Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd.CDE ↗
CYHB2402161Supplement2024/12/18Guilin Pharmaceutical Co.,Ltd.; Shandong Loncom Pharmaceutical Co., Ltd.CDE ↗
维生素B?注射液 · No verified English name 1 records · Latest accepted 2024/11/09

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450560Supplement2024/11/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
马立巴韦片 · No verified English name 1 records · Latest accepted 2024/10/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403523Generic2024/10/18Guilin Pharmaceutical Co.,Ltd.CDE ↗
神曲胃痛片 · No verified English name 1 records · Latest accepted 2024/10/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401967Supplement2024/10/15Guilin Pharmaceutical Co.,Ltd.; Hebei Wan Bang Fu Lin Pharma Co., Ltd. romanizedCDE ↗
Ethyl Iosapentate Capsules 1 records · Latest accepted 2024/09/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403262Generic2024/09/26Guilin Pharmaceutical Co.,Ltd.CDE ↗
青蒿琥酯片 · No verified English name 3 records · Latest accepted 2024/05/25

New drug · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2400527New drug2024/05/25Guilin Pharmaceutical Co.,Ltd.; Shanghai Jiao Tong University romanizedCDE ↗
CXHL2300710New drug2023/06/28Guilin Pharmaceutical Co.,Ltd.; Shanghai Jiao Tong University romanizedCDE ↗
CXHL2101826New drug2021/12/28Guilin Pharmaceutical Co.,Ltd.CDE ↗
Foscarnet Sodium Injection 1 records · Latest accepted 2024/04/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401132Generic2024/04/17Guilin Pharmaceutical Co.,Ltd.; Chi Feng Yuan Sheng Pharma Co., Ltd. romanizedCDE ↗
Peramivir Injection 1 records · Latest accepted 2023/08/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301799Supplement2023/08/15Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd.CDE ↗
Dopamine Hydrochloride Injection 1 records · Latest accepted 2023/06/28

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301404Supplement2023/06/28Guilin Pharmaceutical Co.,Ltd.CDE ↗
Bumetanide Injection 2 records · Latest accepted 2023/03/10

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350251Supplement2023/03/10Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHB2350250Supplement2023/03/10Guilin Pharmaceutical Co.,Ltd.CDE ↗
Tedizolid Phosphate Tablets 1 records · Latest accepted 2023/01/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300180Generic2023/01/19Guilin Pharmaceutical Co.,Ltd.CDE ↗
泊沙康唑注射液 · No verified English name 1 records · Latest accepted 2023/01/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300135Generic2023/01/13Guilin Pharmaceutical Co.,Ltd.CDE ↗
Avatrombopag Maleate Tablets 1 records · Latest accepted 2023/01/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300116Generic2023/01/12Guilin Pharmaceutical Co.,Ltd.CDE ↗
Tolvaptan Tablets 1 records · Latest accepted 2022/09/09

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201625Supplement2022/09/09Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd.CDE ↗
阿普米司特片 · No verified English name 3 records · Latest accepted 2022/09/09

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200763Generic2022/09/09Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200762Generic2022/06/03Guilin Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200761Generic2022/06/03Guilin Pharmaceutical Co.,Ltd.CDE ↗
Amiodarone Hydrochloride Injection 1 records · Latest accepted 2022/09/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201486Generic2022/09/08Guilin Pharmaceutical Co.,Ltd.CDE ↗
Sertraline Hydrochloride Tablets 1 records · Latest accepted 2022/07/05

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201011Generic2022/07/05Guilin Pharmaceutical Co.,Ltd.CDE ↗
氯化钠注射液 · No verified English name 1 records · Latest accepted 2022/01/05

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2200010Supplement2022/01/05Guilin Pharmaceutical Co.,Ltd.CDE ↗
阿普斯特片 · No verified English name 1 records · Latest accepted 2021/05/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101190Generic2021/05/21Guilin Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

2 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 applicationNo longer listed under review: 1 application

  1. 2026/11/10Marketing application approved

    Polymyxin B sulfate for Injection

    CYHS2500394 · 国药准字H20266537

    Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14

    View source · Table row 44 ↗
  2. 2026/10/24No longer listed under review

    Polymyxin B sulfate for Injection

    CYHS2500394

    Fact date: 2026/10/24 · Date added to this site: 2026/10/24

    Accepted: 2025/01/22

    no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266537; approval date: 2026/11/10) · NMPA source · row 44

    NMPA · Table row 44 ↗ View source ↗

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Dotinurad Tablets CYHS2601088Generic2026/05/12Guilin Pharmaceutical Co.,Ltd.CDE ↗
Dotinurad Tablets CYHS2601087Generic2026/05/12Guilin Pharmaceutical Co.,Ltd.CDE ↗
Pemafibrate Tablets CYHS2600973Generic2026/04/28Guilin Pharmaceutical Co.,Ltd.; Beijing Yi Ling Bio Gong Cheng Technology Co., Ltd. romanizedCDE ↗

Catalogue holder records

24 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Isavuconazonium Sulfate for InjectionGuilin Pharmaceutical Co.,Ltd.Suzhou Erye Pharmaceutical Co., Ltd国药准字H202659522026/09/15Generic approved under the new chemical-drug registration classificationCDE ↗
Ethyl Iosapentate CapsulesGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202645462026/05/27Generic approved under the new chemical-drug registration classificationCDE ↗
马立巴韦片 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202643422026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
维生素B6注射液 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202690502026/03/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
利伐沙班干混悬剂 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202560982025/12/03Not stated by sourceCDE ↗
利伐沙班干混悬剂 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Nanjing Hai Na Pharmaceutical Co., Ltd. romanized国药准字H202560992025/12/03Not stated by sourceCDE ↗
Foscarnet Sodium InjectionGuilin Pharmaceutical Co.,Ltd.Chi Feng Yuan Sheng Pharma Co., Ltd. romanized国药准字H202560942025/12/03Not stated by sourceCDE ↗
Azilsartan Medoxomil Potassium TabletsGuilin Pharmaceutical Co.,Ltd.Shandong Loncom Pharmaceutical Co., Ltd.国药准字H202536412025/03/18Generic approved under the new chemical-drug registration classificationCDE ↗
Azilsartan Medoxomil Potassium TabletsGuilin Pharmaceutical Co.,Ltd.Shandong Loncom Pharmaceutical Co., Ltd.国药准字H202536422025/03/18Generic approved under the new chemical-drug registration classificationCDE ↗
泊沙康唑注射液 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202446552024/08/13Generic approved under the new chemical-drug registration classificationCDE ↗
Tedizolid Phosphate TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202439402024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
阿普米司特片 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202436792024/05/15Generic approved under the new chemical-drug registration classificationCDE ↗
阿普米司特片 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202436812024/05/15Generic approved under the new chemical-drug registration classificationCDE ↗
Sertraline Hydrochloride TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202436832024/05/15Generic approved under the new chemical-drug registration classificationCDE ↗
阿普米司特片 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202436802024/05/15Generic approved under the new chemical-drug registration classificationCDE ↗
Amiodarone Hydrochloride InjectionGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202435072024/04/17Generic approved under the new chemical-drug registration classificationCDE ↗
Bumetanide InjectionGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H200572252024/04/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Bumetanide InjectionGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202470662024/04/15Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Aspirin Enteric-coated TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202371162023/09/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Roxithromycin TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H109703962021/11/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Moxifloxacin Hydrochloride TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202138512021/11/03Generic approved under the new chemical-drug registration classificationCDE ↗
Metronidazole TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H450208182021/06/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Linezolid TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202130962021/02/02Generic approved under the new chemical-drug registration classificationCDE ↗
Avatrombopag Maleate TabletsGuilin Pharmaceutical Co.,Ltd.Guilin Pharmaceutical Co.,Ltd.国药准字H202443982024/07/09Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

35 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
托伐普坦磷酸钠 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20250001046I2025/10/13CDE ↗
托伐普坦 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20250000674I2025/07/14CDE ↗
马立巴韦 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20240000993A2026/08/19CDE ↗
布立西坦 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20240000394I2025/10/27CDE ↗
泊沙康唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20230001346A2025/07/18CDE ↗
马来酸阿伐曲泊帕 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20220001118A2025/05/29CDE ↗
乙胺嘧啶 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190009804A—CDE ↗
磺胺多辛 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190009802A—CDE ↗
氟氯西林钠 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190008283A2025/01/18CDE ↗
蒿甲醚 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190007417A2025/01/18CDE ↗
双氢青蒿素 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190006672A2025/01/18CDE ↗
本芴醇 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190005891A2025/01/18CDE ↗
盐酸阿莫地喹 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004856A2025/01/18CDE ↗
联苯双酯 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004305A2025/01/24CDE ↗
诺氟沙星 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004304A2025/01/24CDE ↗
甲硝唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004293A2025/01/18CDE ↗
西洛他唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004271A2025/01/24CDE ↗
牛磺酸 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004267A2025/01/24CDE ↗
盐酸左旋咪唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004104A2025/01/18CDE ↗
青蒿琥酯 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004097A2025/01/18CDE ↗
盐酸胍甲环素 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004094A2025/01/18CDE ↗
乳酶生 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004093A2025/01/18CDE ↗
细辛脑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004092A2025/01/18CDE ↗
阿苯达唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004091A2025/01/18CDE ↗
布美他尼 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004090A2025/01/18CDE ↗
罗红霉素 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004088A2025/01/18CDE ↗
硫酸亚铁 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004085A2025/01/18CDE ↗
鲑降钙素 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004083A2025/01/18CDE ↗
甲苯咪唑 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20190004065A2025/01/18CDE ↗
利奈唑胺 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20180000159A2025/11/15CDE ↗
盐酸莫西沙星 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20170002212A2025/11/15CDE ↗
磺胺多辛 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20170001900A2025/01/18CDE ↗
乙胺嘧啶 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20170001899A2025/01/18CDE ↗
磷酸哌喹 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20170001277I—CDE ↗
萘夫西林钠 · No verified English nameGuilin Pharmaceutical Co.,Ltd.Y20170000332I—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

5 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Edaravone and Dexborneol Concentrated Solution for Injection CYHS2600760Generic2026/04/01Shandong Bai Nuo Pharmaceuticals Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd.CDE ↗
Avatrombopag Maleate Tablets CYHB2500327Supplement2025/02/18Guangxi Nanning Baihui Pharmaceutical Group Co.,Ltd.; Guilin Pharmaceutical Co.,Ltd.CDE ↗
Aspirin Enteric-coated Tablets CYHB2400424Supplement2024/03/26Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd.CDE ↗
Aspirin Enteric-coated Tablets CYHB2400423Supplement2024/03/26Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd.CDE ↗
Aspirin Enteric-coated Tablets CYHB2400422Supplement2024/03/26Chongqing Heng Xin Bio Technology Kai Fa Co., Ltd. romanized; Guilin Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.